600+ sources. One page. See who else covered it.
When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
No Jewish quake-related deaths reported in country's small community, but some families have had to move due to damage, synagogue president says The post After earthquake rocks Colombia, Cali’s Jews…
Photographers in Spain captured spectacular images of the rare alignment of the moon and the sun, as it cast a dark shadow over much of the country
A subcontractor for a module that was being developed for NASA’s lunar Gateway has laid off 70 people after NASA halted work on the program.
The benefit emerged as early as two days after dosing and lasted throughout the 12-week study
Before joining the PMO, Nidhi Tiwari worked with the Ministry of External Affairs on matters related to disarmament and international security.
Gibraltar, Marbella and Lampedusa all lie in the path of totality for the eclipse on 2 August, 2027.